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To determine whether acute hyperglycemia changes the
hyperemic response to functional activation of brain, the
area and magnitude of the activation were measured in
healthy volunteers maintained at euglycemia and then at
hyperglycemia using the hyperglycemic clamp tech-
nique. Activation of the visual cortex (8–16 Hz) was as-
sessed by functional MRI with blood oxygenation level
dependent (BOLD) contrast using a 4 Tesla magnet and
a multi-slice echo-planar imaging sequence (TE 5 30
msec, TR 5 1.5 sec). At euglycemia (4.8 6 0.2 mM,
mean 6 SEM, n 5 6), the number of activated pixels in
the occipital lobe was 79 6 10 and the intensity of
activation was 4.5 6 0.5%. During hyperglycemia (plas-
ma glucose 300% of control), the number of activated
pixels was 90 6 20% of control and the BOLD activation
was 3.5 6 0.3%, respectively. The change in BOLD
signal was below 0.2%/mM plasma glucose. This study
demonstrates that acute hyperglycemia is without sub-
stantial effect on the size and intensity of activation of the
occipital cortex. The results further suggest that fluctua-
tions in blood glucose within the physiologic range are
without effect on the functional activation of the cerebral
cortex measured by BOLD fMRI. J. Neurosci. Res. 62:
279–285, 2000. © 2000 Wiley-Liss, Inc.
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Changes in serum glucose concentrations have long
been recognized to have cerebral effects. Acute changes in
glycemia, like that seen in patients with hyperosmolar
coma, can lead to hemiparesis and confusion (Arieff and
Carroll, 1972) whereas chronic hyperglycemia has been
linked to impairments in cognitive function, particularly
with respect to memory and visual/spatial reasoning in
children with type 1 diabetes (Haumont et al., 1979;
Rovet and Alvarez, 1997; Ryan et al., 1992) and in older
adults with type 2 diabetes (Perlmutter et al., 1984;
Reaven et al., 1990; Langen et al., 1991). Measures of
electrical potentials evoked in response to auditory or
visual stimuli have also been found to be decreased in
patients with diabetes mellitus (Khardori et al., 1986;
Pozzessere et al., 1988; Nakamura et al., 1991; Uccioli et
al., 1995; Comi, 1997; Parisi et al., 1997). In addition,
acute elevations in serum glucose concentration have also
been reported to decrease cerebral blood flow in experi-
mental animals (Duckrow et al., 1987; Harik and La-
Manna, 1988). Whether acute increases in glycemia have
an effect on the hyperemic response to functional activa-
tion is uncertain. As more in vivo investigation of the
cerebral cortex relies on the injection of labeled glucose to
monitor cerebral metabolism (Gruetter et al., 1999; Gru-
etter et al., 1998; Shen et al., 1999), however, understand-
ing the effect of acute hyperglycemia on functional acti-
vation will be essential for accurate data interpretation.
Brain activation has been studied in vivo using
positron emission tomography (PET) and functional mag-
netic resonance imaging (fMRI). Although PET has been
successful in mapping brain function to certain areas, it
requires exposure to radioactivity (Watson, 1997). Func-
tional magnetic resonance imaging presents an alternative
method with less risk to the subject. With this technique,
individuals are provided a stimulus of the central nervous
system and the activated neural tissue is detected through
the use of BOLD (blood oxygenation level dependent)
MRI signals (Ogawa and Lee 1990; Ogawa et al., 1990,
1992, 1993; Bandettini et al., 1992; Kwong et al., 1992).
It seems to be a general phenomenon that during focal
brain activation, blood flow increases disproportionately
relative to the increase in the amount of oxygen extracted,
resulting in a net reduction of venous deoxyhemoglobin.
Deoxyhemoglobin is a paramagnetic molecule that has
been shown to act as an endogenous contrast agent on the
bulk water signal and thus a change in deoxyhemoglobin
content can change MRI signal intensity by several per-
cent. Typically, areas of activation are identified by com-
paring pixel intensities in the MRI measured during a
control and a task state.
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We and others have recently begun to determine the
effect of functional activation on rates of cerebral energy
metabolism (Hyder et al., 1996; Chen et al., 2000). In such
studies, an infusion of 1-13C-glucose is used to monitor
rates of glucose metabolism in an area responding to a
neural stimulus. Whether the acute elevation of serum
glucose that typically follows the infusion of 13C-labeled
glucose affects fMRI of functional activation is uncertain.
In the current investigation we sought to address this
question. We used fMRI with BOLD contrast to deter-
mine whether acute hyperglycemia alters the size of the
brain area or the intensity of activation during visual
stimulation in healthy humans. We found that the func-
tional activation of the visual cortex was not altered by
experimental hyperglycemia. Based on this study, we pro-
pose that interpretation of fMRI data obtained during
moderate hyperglycemia after the infusion of labeled glu-
cose does not depend in a substantial way on the plasma
glucose concentration at euglycemia or above.
MATERIALS AND METHODS
Subjects were recruited from the University of Minnesota
community and were studied in the morning after an 8–10 hr
fast using procedures approved by the Institutional Review
Board. Subjects were prepared for the study by placing intrave-
nous catheters into veins in each arm and in the distal leg. The
catheters in the arms were used for the infusion of somatostatin
and glucose and the catheter in the leg was used for venous
sampling. Venous blood in the extremities was arterialized
throughout the study by the continuous administration of
Temp-Aid Hot Packs (Baxter Healthcare Corporation, Valen-
cia, CA) and heated towels (Seaquist, 1997). At Time 0, subjects
were infused with somatostatin (0.16 mg/kg/min) to suppress
endogenous insulin secretion and euglycemia was maintained
through the intravenous infusion of 20% glucose as needed.
Subjects were then placed into the magnet, and after adjusting
the MR scanner, presented with a visual task. When the task was
completed, plasma glucose was increased by a bolus infusion of
20% or 50% glucose in water. After plasma glucose had been
maintained at a stable hyperglycemic level that was at least 50%
above euglycemia for 20 or more minutes, the visual stimulation
task was again presented and the magnetic resonance measures
were repeated identically. Throughout the study, blood samples
for glucose measurement were obtained every 5 min and sam-
ples for insulin were drawn every 20 min. Plasma glucose
concentrations were measured using a Beckman Autoanalyzer
(Fullerton, CA) and insulin concentrations were determined by
radioimmunoassay (Morgan and Lazarow, 1963).
Functional MRI was performed using a 4Tesla/125 cm
magnet equipped with an unshielded gradient coil insert (30
mT/m in 200 ms, 31 cm inner diameter). Images were acquired
using echo-planar imaging (EPI; 64 3 64 image size, 20 cm field
of view) with an echo time TE 5 30 msec and a repetition time
TR 5 1.5 sec and a 450 flip angle for the slice selective
excitation pulse. Five coronal slices (5 mm thickness) with
7.5 mm inter-slice distance were acquired in an interleaved
fashion that covered the extent of the calcarine fissure. Shim-
ming of a 30 ml large region of interest was done using all first
and second order shim coils with FASTMAP (Gruetter 1993),
that resulted in a 7–9 Hz full width at half height for the water
signal in 27 ml vol in the occipital lobe. Visual stimulation was
performed using a standard GRASS stimulator set at 8–16 Hz
using home-built LED goggles (Ogawa et al., 1993). The gog-
gles were alternated starting with currents turned off, according
to the following pattern: OFF (45 sec)–ON (30 sec)–OFF (30
sec)–ON (30 sec)–OFF (45 sec) with a total duration of 180 sec.
One hundred-twenty images per slice were thus collected.
Data analysis was performed on images 6–115, that omitted the
first and last 7.5 seconds of the trial period.
Image analysis was performed using STIMULATE soft-
ware (Ugurbil). Activated pixels were identified by comparing
the fMRI signal before activation (e.g., average of images 6–15)
to that during activation (e.g., average of images 18–25) by
accounting for a small delay in hemodynamic response. Like-
wise, signal change was tested by comparing activated signal to
the subsequent period where goggles were turned off. Given
that two stimulation periods were used, this resulted in 4 statis-
tical tests, namely one each for a signal increase at the onset of
the first and second stimulus, respectively, and one each for a
signal decrease at the end of the first and second stimulus,
respectively. Pixels were considered activated only if motion was
determined to be insignificant based on center-of-mass time
courses and verification of lack of negative signal changes at the
tissue edges for each of the 4 tests performed. Pixels that dis-
played a significant (P , 0.01, two-tailed t-test) difference in
intensity between basal and stimulated conditions were included
in the statistical analysis. To determine the size of the cortex
responsive to visual stimulation, the number of significantly
activated pixels identified in the region of interest were counted
within a 30 ml region of interest that was identified relative to
anatomic landmarks to encompass the calcarine fissure. The
position and size of this VOI was identical for the hyperglycemic
and euglycemic trial in any given subject. The intensity of the
activation was determined by calculating the percentage change
in MR signal (the % BOLD effect) noted between basal and
activated conditions in those pixels identified by statistical
t-testing. The identical analysis was performed on data collected
during eu- and hyperglycemia.
Data are expressed as mean 6 SEM. Statistical differences
between euglycemic and hyperglycemic conditions were eval-
uated using Student’s t-test for paired data as well as the non-
parametric sign test. A P value ,0.05 was considered statistically
significant.
RESULTS
Five healthy female subjects participated in this
study. One subject was studied on two separate occasions,
resulting in six studies. Their mean age was 40 6 3 years
and their mean weight was 72.4 6 3.9 kg. For each study,
subjects were studied sequentially at euglycemia (plasma
glucose ranging from 4.5–6.0 mM) and hyperglycemia
(9.6–18.6 mM) within 2 hr. The hyperglycemic phase of
the study was performed at least 20 min after the eugly-
cemic part of the protocol, that is detailed in Figure 1.
Plasma insulin concentrations were below 30 pM in all
studies.
Activation images color-coded for statistical signifi-
cance or percent BOLD signal change were constructed
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for all subjects during eu- and hyperglycemic conditions
by including only pixels considered activated. An example
of such a map obtained from a single subject during
euglycemia is shown in Figure 2. The number of pixels
activated during euglycemia was not significantly different
from the number of pixels activated during hyperglycemia
(Table I). The number of pixels activated during hyper-
glycemia (70 6 16) corresponds to 90 6 20% of the
number of pixels activated during euglycemia. Likewise,
the BOLD effect was similar at both levels of glycemia
(4.5 6 0.5% vs. 3.5 6 0.3%, P 5 NS, Table I). When
examining the differences using paired t-test, however, a
significant change was found.
To further examine the effect of increased plasma
glucose concentration on the intensity of activation, we
extracted the time courses for each activated pixel and
calculated the average MRI signal change for each study.
These data were then averaged over all 6 studies to yield
the two fMRI time courses shown in Figure 3A. As shown
in the figure, the image intensity varied under both gly-
cemic conditions as the visual stimulus was turned on and
off. When a difference curve was created by subtracting
the average time course acquired at hyperglycemia (Fig.
3A top; left scale) from that acquired during euglycemia
(Fig. 3A middle; left scale), a flat line within the back-
ground noise of the measurement was obtained (Fig. 3A
bottom; right scale). No statistically significant difference
was found between the data acquired during eu- and
hyperglycemia. Although this difference time course is
consistently above zero, this difference cannot be consid-
Fig. 2. Activation maps acquired during euglycemia in the same subject. The activation map (coronal
orientation intersecting the calcarine fissure) is overlaid on an image generated with the same imaging
sequence, EPI (TR 5 1.5 sec, TE-30 msec, 45° flip angel, 64 phase encode steps).
Fig. 1. Experimental protocol. Shown
are the plasma glucose concentrations
measured in a single subject during our
study protocol. Subjects underwent a
two step clamp procedure with fMRI
performed during stable euglycemia and
stable hyperglycemia. Plasma glucose
was controlled by adjusting the rate of
the glucose infusion based on plasma
glucose concentrations measured every
5 min.
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ered significant, as one study showed a decrease in the
difference activation curve (P . 0.05 using the sign test).
To determine whether a trend in the BOLD effect was
discernible, the BOLD effect was plotted as a function of
plasma glucose, shown in Figure 3B. Regression analysis
indicated that r2 was 0.18 and the statistical test for corre-
lation was not significant (P . 0.05). The slope was
20.00077 6 0.0005/mM plasma glucose, that corre-
sponds to a 0.0860.05% change per mM plasma glucose
and thus was considered negligible (P . 0.05). When
calculating the change in BOLD effect for each subject
individually, a slope of 0.12 6 0.04%/mM change in
plasma glucose was calculated.
DISCUSSION
The effect of acute hyperglycemia on the cerebral
response to a visual stimulus was studied in volunteers
using functional magnetic resonance imaging with BOLD
contrast. Both the size of the region activated by a visual
stimulus as well as the intensity of that activation was
equivalent and within the experimental error of the
method during euglycemia as compared to a 3-fold ele-
vation in plasma glucose concentration. These data pro-
vide support for the hypothesis that acute hyperglycemia,
at least within the range studied in these experiments, is
without substantial effect on the perception of a visual
stimulus in humans.
When comparing the BOLD effect within each sub-
ject, however, a significant effect due to the supraphysi-
ologic hyperglycemia was noted. The change in BOLD
effect was 0.12%/mM plasma glucose, that implies that the
magnitude of the BOLD signal decreases at most by 0.5%
for the typical physiological range of plasma glucose be-
tween 5 and 10 mM. Because the area of activation was
unchanged, such a small change in BOLD signal implies
that physiologic changes in plasma glucose concentration
are without concern to brain activation studies of the
human visual cortex, as further emphasized by Figure 3A.
The fact that these changes only reached statistical signif-
icance when using the paired (intra-individual) test, im-
plies that inter-individual differences are larger and that
they effectively mask a small change in BOLD signal
during hyperglycemia, that is quantitatively of minor im-
portance.
The effect of hyperglycemia on cerebral function in
humans has been difficult to define. Although abnormal-
ities in evoked responses (Pozzessere et al., 1988) and
neuropsychological functioning (Reaven et al., 1990) have
been linked to poor glycemic control in patients with
diabetes, distinguishing between the effects of acute and
chronic hyperglycemia has been problematic in humans
because meticulous control of the glycemia experienced
by the subject before or during the study has not always
been achieved. In this investigation, normal subjects were
studied during euglycemia and a subsequent acute 2- to
3-fold elevation of their plasma glucose concentration
using the glucose/insulin clamp procedure. Because
BOLD contrast relies on the interplay between cerebral
blood flow, cerebral blood volume, and cerebral oxygen
consumption (Ogawa et al., 1998), our observations sug-
gest that acute hyperglycemia such as that experienced in
response to high carbohydrate feeding after a nocturnal fast
is without effect on these variables. Our experiments fo-
cused on functional activation in the visual cortex, that is
a highly reproducible activation paradigm. Acute hyper-
glycemia might alter functional activation in other brain
regions, but given the universal detection of the BOLD
effect, this may occur only in highly specialized brain
regions.
In the present study, endogenous insulin secretion
was minimized by an infusion of somatostatin, leading to
undetectable concentrations of insulin in the blood. Al-
though this protocol effectively controlled for differences
in insulin concentrations among study subjects, it does not
allow us to determine whether insulin itself has an effect
on brain activation. Insulin receptors have been identified
in the brain (Hill et al., 1986; Werther et al., 1992) and the
vasculature of other tissues has been shown to be respon-
sive to the vasodilatory effects of insulin (Laakso et al.,
1990; Baron et al., 1995; Yki-Jarvinen and Utriainen,
1998). A recent study by Cranston et al. (1998) in which
diabetic subjects were studied by PET scanning in the
absence and presence of insulin, however, demonstrated
that cerebral blood flow was the same under both exper-
TABLE I. Summary of Data from Individual fMRI Studies
Study
Euglycemia Hyperglycemia
Plasma glucose
(mM)
No. of activated pixels
(P , 0.01)
BOLD
(%)
Plasma glucose
(mM)
No. of activated pixels
(P , 0.01)
BOLD
(%)
1 4.6 82 5.1 17.4 79 4.5
2 5.8 59 5.3 18.6 54 3.2
3 4.6 68 5.9 11.2 80 4.1
4 4.6 52 3.8 9.6 137 3.0
5 4.5 121 2.9 16.1 30 2.8
6 4.5 91 4.1 13.8 38 3.5
Mean 6 SEM 4.8 6 0.2 79 6 10 4.5 6 0.5 14.5 6 1.5 70 6 16 3.5 6 0.3
Data shown are obtained from six studies performed on five subjects. The size of the area of activation is indicated by the number of activated pixels and
the intensity of activation is indicated by BOLD %.
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Fig. 3. Average time courses at eu- and at hyperglycemia. A: Shown are the time courses averaged
over all six studies at euglycemia and at hyperglycemia during the task shown above (left scale; boxes
above [on/off] indicate when visual stimulus was on or off, respectively). The average relative
difference between the two is shown with the same scaling (right scale). B: Shown is the BOLD effect
in fractional signal change for each of the six studies as a function of plasma glucose.
imental conditions. Consequently, we think it is unlikely
that our experimental approach of suppressing insulin se-
cretion by the infusion of somatostatin masked a physio-
logically relevant effect of insulin on blood flow that could
confound our efforts to determine the effects of hypergly-
cemia on brain activation.
In summary, severe acute hyperglycemia does not
seem to have a substantial effect on BOLD imaging during
visual stimulation in healthy humans. Under supraphysi-
ologic concentrations of blood glucose we found the size
of the area of brain activated by the GRASS stimulator
comparable to that measured during euglycemia. Al-
though the intensity of the activation was significantly
reduced, the correlation with plasma glucose was not
significant. Our observations have relevance to studies of
functional activation where cellular metabolism is moni-
tored with labeled glucose. In such work investigators may
now be certain that any functional changes noted are the
result of their experimental manipulation and are not due
to the acute hyperglycemia often necessary to perform the
study. Our experiments also show that variation in blood
glucose does not affect the BOLD signal substantially,
providing further evidence that fMRI with BOLD is a
robust modality for imaging brain function during physi-
ologic variations in plasma glucose concentrations.
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